All updated as on -
During the forecast period (2023-2030), the size of the global adhesion barrier market is expected to increase from USD 0.69 billion in 2023 to USD 1.08 billion by 2030, representing a CAGR of 8.22%. In 2022, the market was valued at USD 0.9 billion.
Rising healthcare costs around the world and an uptick in the number of surgical procedures and sports-related injuries are fueling this expansion. As the number of surgeries increases, especially orthopaedic and cardiac procedures, the demand for adhesion barriers is likely to rise. The need for these barriers is boosted by the prevalence of sports injuries and accidental injuries. Surgical procedures are becoming increasingly necessary due to the rising number of injuries sustained in the United States from activities such as bicycling, exercise, and the use of recreational vehicles. Because of rising populations and rising need for medical equipment, developing countries will contribute to market growth. As earnings rise, so is people's propensity to spend a larger portion of them on healthcare in these countries. Therefore, we anticipate a rise in the use of cutting-edge products such as adhesion barriers. While the industry is expected to expand, it will face obstacles such as the high price of surgical treatments, the risks connected with adhesion barriers, and restrictions that restrict technical advancements.
Product-Level Analyses
During the projected time frame, the market segment is projected to expand at a rapid clip. The advantages of synthetic adhesion barriers include their portability, low price, and adaptability. Because of its high biocompatibility and biodegradability, the hyaluronic acid market is expected to expand rapidly in the coming years. As a result of their effectiveness in reducing postoperative problems and adhesion formation, these synthetic adhesion barriers have gained favour in a variety of surgical procedures, most notably abdominal, gynaecological, and cardiovascular operations.
Although synthetic adhesion barriers are the market leaders, natural adhesion barriers like collagen and fibrin also play an important role in the industry's development. Adhesion barriers made of collagen are commonly utilised in orthopaedic procedures because of their potential to reduce adhesions and speed tissue healing. Adhesion barriers made of fibrin are frequently utilised in neurosurgery and cardiovascular surgery.
Formulation-Based Analyses
The market for adhesion barriers is predicted to expand significantly, especially in the film formulation category. Films' benefits include their simplicity of application, adaptability, and tissue-following conformity. They're commonly utilised in surgeries to cut down on adhesions and subsequent problems. This market is expanding due to the increasing use of film-based adhesion barriers in a wide range of surgical procedures, such as general/abdominal, gynaecological, and orthopaedic procedures.
A sizable portion of the market is also held by the liquid formulation subsegment, which is anticipated to expand at a healthy clip. Sprays and irrigants made of liquid adhesion barriers are used in surgical procedures. They are applied to the tissues to establish a coating and physical barrier against adhesion formation. When a film or gel's direct application would be difficult or impracticable, a liquid formulation would be ideal. Easy application, adaptability, and reliable adhesion prevention have all contributed to the rise in popularity of liquid adhesion barriers.
Methodology of Use Analysis
Hysterectomies, myomectomies, and ovarian operations are all examples of the kinds of gynaecological surgery that can be performed. Due to the prevalence of disorders including endometriosis and fibroids, the market for adhesion barriers in gynaecological procedures is likely to continue stable rise. While gynaecological operations may have a smaller market share than general or abdominal surgeries, they are nonetheless important.
The heart and blood vessels are the focus of the Cardiovascular Surgeries section, which covers treatments including coronary artery bypass grafting (CABG), valve replacement, and angioplasty. The market for adhesion barriers is predicted to increase steadily, despite the fact that their use in cardiovascular procedures is likely to remain low compared to that in other fields. Although cardiovascular surgery's part of the market is now very small, this could grow as new technologies become available. Joint replacements, fracture fixes, and spinal operations are all examples of the kinds of procedures that fall under the umbrella of "orthopaedic surgery." As the incidence of orthopaedic disorders and the quantity of surgical procedures both rise, so too will the need for adhesion barriers during orthopaedic procedures. Due to the widespread application of adhesion barriers in orthopaedics, this subsegment is poised to capture a sizable portion of the market.
Several major businesses are present in the market, each of which is vying for a larger slice of the pie. In order to maintain or increase their market share, these businesses invest heavily in new products, partnerships, mergers, and expansions into new regions. These businesses spend money on R&D to create new adhesion barriers that perform better and are safer for consumers. In addition, they do advertising and public relations work to inform doctors and patients about the advantages of adhesion barriers during surgery. As businesses seek to set themselves apart from rivals in the marketplace by developing novel products and expanding their reach into new and existing markets, the playing field is predicted to heat up.
Report Coverage
Global Adhesion Barrier research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Adhesion Barrier report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Adhesion Barrier competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Adhesion Barrier market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Adhesion Barrier market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Adhesion Barrier market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Baxter International Inc. - United States, Anika Therapeutics, Inc. - United States, Sanofi SA - France, Medtronic plc - Ireland, Integra LifeSciences Corporation - United States, Atrium Medical Corporation (Getinge AB) - United States, FzioMed, Inc. - United States, MAST Biosurgery AG - Switzerland, Terumo Corporation - Japan, Johnson & Johnson - United States, C. R. Bard, Inc. (Now part of Becton, Dickinson and Company) - United States, B. Braun Melsungen AG - Germany, MAST Biosurgery AG - Switzerland, Tissuemed Ltd. (Integra LifeSciences Corporation) - United Kingdom, Ferring Pharmaceuticals - Switzerland, Adhesion Barrier Company - United States, Fidia Farmaceutici S.p.A. - Italy, Innocoll Holdings PLC - Ireland, Biom'Up SAS (Zimmer Biomet Holdings, Inc.) - France, Aziyo Biologics, Inc. - United States
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Adhesion Barrier market based on the below-mentioned segments:
Global Adhesion Barrier Market, By Product
Synthetic Adhesion Barriers
Natural Adhesion Barriers
Global Adhesion Barrier market, By Application
Gynecological Surgeries
Abdominal General Surgeries
Orthopedic Surgeries
Cardiovascular Surgeries
Neurological Surgeries
Urological Surgeries
Others
Global Adhesion Barrier Market, By Formulation
Film/Mesh
Gel
Liquid
Global Adhesion Barrier market, Regional Analysis
Rising healthcare costs around the world and an uptick in the number of surgical procedures and sports-related injuries are fueling this expansion. As the number of surgeries increases, especially orthopaedic and cardiac procedures, the demand for adhesion barriers is likely to rise. The need for these barriers is boosted by the prevalence of sports injuries and accidental injuries. Surgical procedures are becoming increasingly necessary due to the rising number of injuries sustained in the United States from activities such as bicycling, exercise, and the use of recreational vehicles. Because of rising populations and rising need for medical equipment, developing countries will contribute to market growth. As earnings rise, so is people's propensity to spend a larger portion of them on healthcare in these countries. Therefore, we anticipate a rise in the use of cutting-edge products such as adhesion barriers. While the industry is expected to expand, it will face obstacles such as the high price of surgical treatments, the risks connected with adhesion barriers, and restrictions that restrict technical advancements.
Product-Level Analyses
During the projected time frame, the market segment is projected to expand at a rapid clip. The advantages of synthetic adhesion barriers include their portability, low price, and adaptability. Because of its high biocompatibility and biodegradability, the hyaluronic acid market is expected to expand rapidly in the coming years. As a result of their effectiveness in reducing postoperative problems and adhesion formation, these synthetic adhesion barriers have gained favour in a variety of surgical procedures, most notably abdominal, gynaecological, and cardiovascular operations.
Although synthetic adhesion barriers are the market leaders, natural adhesion barriers like collagen and fibrin also play an important role in the industry's development. Adhesion barriers made of collagen are commonly utilised in orthopaedic procedures because of their potential to reduce adhesions and speed tissue healing. Adhesion barriers made of fibrin are frequently utilised in neurosurgery and cardiovascular surgery.
Formulation-Based Analyses
The market for adhesion barriers is predicted to expand significantly, especially in the film formulation category. Films' benefits include their simplicity of application, adaptability, and tissue-following conformity. They're commonly utilised in surgeries to cut down on adhesions and subsequent problems. This market is expanding due to the increasing use of film-based adhesion barriers in a wide range of surgical procedures, such as general/abdominal, gynaecological, and orthopaedic procedures.
A sizable portion of the market is also held by the liquid formulation subsegment, which is anticipated to expand at a healthy clip. Sprays and irrigants made of liquid adhesion barriers are used in surgical procedures. They are applied to the tissues to establish a coating and physical barrier against adhesion formation. When a film or gel's direct application would be difficult or impracticable, a liquid formulation would be ideal. Easy application, adaptability, and reliable adhesion prevention have all contributed to the rise in popularity of liquid adhesion barriers.
Methodology of Use Analysis
Hysterectomies, myomectomies, and ovarian operations are all examples of the kinds of gynaecological surgery that can be performed. Due to the prevalence of disorders including endometriosis and fibroids, the market for adhesion barriers in gynaecological procedures is likely to continue stable rise. While gynaecological operations may have a smaller market share than general or abdominal surgeries, they are nonetheless important.
The heart and blood vessels are the focus of the Cardiovascular Surgeries section, which covers treatments including coronary artery bypass grafting (CABG), valve replacement, and angioplasty. The market for adhesion barriers is predicted to increase steadily, despite the fact that their use in cardiovascular procedures is likely to remain low compared to that in other fields. Although cardiovascular surgery's part of the market is now very small, this could grow as new technologies become available. Joint replacements, fracture fixes, and spinal operations are all examples of the kinds of procedures that fall under the umbrella of "orthopaedic surgery." As the incidence of orthopaedic disorders and the quantity of surgical procedures both rise, so too will the need for adhesion barriers during orthopaedic procedures. Due to the widespread application of adhesion barriers in orthopaedics, this subsegment is poised to capture a sizable portion of the market.
Several major businesses are present in the market, each of which is vying for a larger slice of the pie. In order to maintain or increase their market share, these businesses invest heavily in new products, partnerships, mergers, and expansions into new regions. These businesses spend money on R&D to create new adhesion barriers that perform better and are safer for consumers. In addition, they do advertising and public relations work to inform doctors and patients about the advantages of adhesion barriers during surgery. As businesses seek to set themselves apart from rivals in the marketplace by developing novel products and expanding their reach into new and existing markets, the playing field is predicted to heat up.
Report Coverage
Global Adhesion Barrier research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Adhesion Barrier report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Adhesion Barrier competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Adhesion Barrier market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Baxter International Inc. - United States, Anika Therapeutics, Inc. - United States, Sanofi SA - France, Medtronic plc - Ireland, Integra LifeSciences Corporation - United States, Atrium Medical Corporation (Getinge AB) - United States, FzioMed, Inc. - United States, MAST Biosurgery AG - Switzerland, Terumo Corporation - Japan, Johnson & Johnson - United States, C. R. Bard, Inc. (Now part of Becton, Dickinson and Company) - United States, B. Braun Melsungen AG - Germany, MAST Biosurgery AG - Switzerland, Tissuemed Ltd. (Integra LifeSciences Corporation) - United Kingdom, Ferring Pharmaceuticals - Switzerland, Adhesion Barrier Company - United States, Fidia Farmaceutici S.p.A. - Italy, Innocoll Holdings PLC - Ireland, Biom'Up SAS (Zimmer Biomet Holdings, Inc.) - France, Aziyo Biologics, Inc. - United States |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Adhesion Barrier Market from 2021 to 2030.
- Market Forecast for Adhesion Barrier Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Adhesion Barrier competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Adhesion Barrier
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Adhesion Barrier market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Adhesion Barrier market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Baxter International Inc. - United States, Anika Therapeutics, Inc. - United States, Sanofi SA - France, Medtronic plc - Ireland, Integra LifeSciences Corporation - United States, Atrium Medical Corporation (Getinge AB) - United States, FzioMed, Inc. - United States, MAST Biosurgery AG - Switzerland, Terumo Corporation - Japan, Johnson & Johnson - United States, C. R. Bard, Inc. (Now part of Becton, Dickinson and Company) - United States, B. Braun Melsungen AG - Germany, MAST Biosurgery AG - Switzerland, Tissuemed Ltd. (Integra LifeSciences Corporation) - United Kingdom, Ferring Pharmaceuticals - Switzerland, Adhesion Barrier Company - United States, Fidia Farmaceutici S.p.A. - Italy, Innocoll Holdings PLC - Ireland, Biom'Up SAS (Zimmer Biomet Holdings, Inc.) - France, Aziyo Biologics, Inc. - United States
Primary Target Market
- Market Players of Adhesion Barrier
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Adhesion Barrier market based on the below-mentioned segments:
Global Adhesion Barrier Market, By Product
Synthetic Adhesion Barriers
Natural Adhesion Barriers
Global Adhesion Barrier market, By Application
Gynecological Surgeries
Abdominal General Surgeries
Orthopedic Surgeries
Cardiovascular Surgeries
Neurological Surgeries
Urological Surgeries
Others
Global Adhesion Barrier Market, By Formulation
Film/Mesh
Gel
Liquid
Global Adhesion Barrier market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive adhesion barrier market market research and competitor analysis for your business to help you develop more profound insights into the adhesion barrier market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the adhesion barrier market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.